InvestorsObserver
×
News Home

ABVC Biopharma Inc (ABVC) has fallen 2.34% Wednesday In Premarket Trading

Wednesday, March 27, 2024 07:33 AM | InvestorsObserver Analysts

Mentioned in this article

ABVC Biopharma Inc (ABVC) has fallen 2.34% Wednesday In Premarket Trading

ABVC Biopharma Inc (ABVC) is down Wednesday morning, with the stock declining -2.34% in pre-market trading to 1.25. ABVC's short-term technical score of 36 indicates that the stock has traded less bullishly over the last month than 64% of stocks on the market. In the Biotechnology industry, which ranks 100 out of 146 industries, ABVC Biopharma Inc ranks higher than 50% of stocks. ABVC Biopharma Inc has risen 6.67% over the past month, closing at $1.22 on February 28. During this period of time, the stock fell as low as $1.05 and as high as $1.29.

Overall Score - 16
ABVC has an Overall Score of 16. Find out what this means to you and get the rest of the rankings on ABVC!
ABVC Biopharma Inc has a Long-Term Technical rank of 11. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 89% of the market scoring higher. In the Biotechnology industry which is number 69 by this metric, ABVC ranks better than 69% of stocks.

Important Dates for Investors in ABVC:

-ABVC Biopharma Inc is set to release earnings on 2024-05-20. Over the last 12 months, the company has reported EPS of $-3.57. -We do not have a set dividend date for ABVC Biopharma Inc at this time. Click Here To Get The Full Report on ABVC Biopharma Inc (ABVC)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App